A report by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Special Task Force on U.S. Value Assessment Frameworks takes a look at the role value assessments play in the U.S. health care system.
The report is one in a series of reports published in ISPOR’s Value in Health.
“Concerns about rising spending on prescription drug prices and in other areas of health care have led to multiple initiatives in the United States designed to measure and communicate the value of pharmaceuticals and other health care technologies for decision making,” the report says.
Several organizations have moved toward a value assessment framework include the American College of Cardiology/American Heart Association, the American Society of Clinical Oncology, the Institute for Clinical and Economic Review, the Memorial Sloan Kettering Cancer Center and the National Comprehensive Cancer Network.
To read the full report, click here.